Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.

Dramis A, Grimer RJ, Malizos K, Tillman RM, Jeys L, Carter LR.

Acta Orthop Belg. 2016 Aug;82(2):216-221.

PMID:
27682283
2.

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.

Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW.

J Clin Oncol. 2000 Sep;18(17):3108-14.

PMID:
10963639
3.

Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.

Evans R, Nesbit M, Askin F, Burgert O, Cangir A, Foulkes M, Gehan E, Gilula L, Kissane J, Makley J, et al.

Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):129-36.

PMID:
3881374
4.

[Treatment of pelvic Ewing's sarcoma in children and the effect on the skeletal growth and development].

Fu J, Guo Z, Wang Z, Li XD, Li J, Chen GJ, Wu ZG.

Zhonghua Zhong Liu Za Zhi. 2012 Dec;34(12):927-31. doi: 10.3760/cma.j.issn.0253-3766.2012.12.010. Chinese.

PMID:
23336380
5.

Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.

Oksüz DC, Tural D, Dincbas FÖ, Dervisoglu S, Turna H, Hiz M, Kantarci F, Ceylaner B, Koca S, Mandel NM.

Tumori. 2014 Jul-Aug;100(4):452-8. doi: 10.1700/1636.17910.

PMID:
25296596
6.

Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.

Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O Jr, Vietti TJ, Cangir A, Tefft M, Thomas P, Askin FB, et al.

J Clin Oncol. 1991 Jul;9(7):1173-80.

PMID:
2045857
7.

Ewing's sarcoma of the pelvis.

Capanna R, Toni A, Sudanese A, McDonald D, Bacci G, Campanacci M.

Int Orthop. 1990;14(1):57-61.

PMID:
2341215
8.

Survival of patients with Ewing's sarcoma in Yazd-Iran.

Akhavan A, Binesh F, Shamshiri H, Ghanadi F.

Asian Pac J Cancer Prev. 2014;15(12):4861-4.

9.

Surgical indications for Ewing's sarcoma of the pelvis.

Yang RS, Eckardt JJ, Eilber FR, Rosen G, Forscher CA, Dorey FJ, Kelly CM, al-Shaikh R.

Cancer. 1995 Oct 15;76(8):1388-97.

PMID:
8620413
10.

Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Sharma DN, Thulkar S, Vishnubhatla S, Pathania S, Bakhshi S.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9. doi: 10.1016/j.clon.2014.05.006. Epub 2014 Jun 8.

PMID:
24919857
11.

[Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].

Peng RJ, Sun XF, Xiang XJ, Zhen ZJ, Ling JY, Tong GL, Xia Y, Xu GC, Jiang WQ.

Ai Zheng. 2009 Dec;28(12):1304-9. Chinese.

PMID:
19958626
12.

Pelvic Ewing's sarcoma: a review from Scottish Bone Tumour Registry.

Bhagat S, Sharma H, Pillai DS, Jane MJ.

J Orthop Surg (Hong Kong). 2008 Dec;16(3):333-8.

PMID:
19126901
13.

Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.

Albergo JI, Gaston CL, Laitinen M, Darbyshire A, Jeys LM, Sumathi V, Parry M, Peake D, Carter SR, Tillman R, Abudu AT, Grimer RJ.

Bone Joint J. 2016 Aug;98-B(8):1138-44. doi: 10.1302/0301-620X.98B8.37346.

PMID:
27482030
14.

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

Paulussen M, Ahrens S, Burdach S, Craft A, Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A, Jürgens H.

Ann Oncol. 1998 Mar;9(3):275-81.

PMID:
9602261
15.

Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?

Pradhan A, Grimer RJ, Spooner D, Peake D, Carter SR, Tillman RM, Abudu A, Jeys L.

J Bone Joint Surg Br. 2011 Apr;93(4):531-6. doi: 10.1302/0301-620X.93B4.25510.

PMID:
21464495
16.

Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.

Nesbit ME Jr, Gehan EA, Burgert EO Jr, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM, et al.

J Clin Oncol. 1990 Oct;8(10):1664-74.

PMID:
2213103
17.

Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Baldini EH, Demetri GD, Fletcher CD, Foran J, Marcus KC, Singer S.

Ann Surg. 1999 Jul;230(1):79-86.

18.

Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.

Arpaci E, Yetisyigit T, Seker M, Uncu D, Uyeturk U, Oksuzoglu B, Demirci U, Coskun U, Kucukoner M, Isıkdogan A, Inanc M, Alkis N, Ozkan M.

Med Oncol. 2013 Mar;30(1):469. doi: 10.1007/s12032-013-0469-z. Epub 2013 Jan 24.

PMID:
23345116
19.

The effect of surgery with radiation on pelvic Ewing sarcoma survival.

Ng VY, Jones R, Bompadre V, Louie P, Punt S, Conrad EU 3rd.

J Surg Oncol. 2015 Dec;112(8):861-5. doi: 10.1002/jso.24081. Epub 2015 Nov 3.

PMID:
26525492
20.

Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery.

Bacci G, Ferrari S, Longhi A, Versari M, Forni C, Donati D, Manfrini M, Trentani P, Barbieri E.

J Bone Joint Surg Br. 2003 Jan;85(1):107-14.

PMID:
12585587

Supplemental Content

Support Center